The CLARA Study From the Acute Leukemia French Association (ALFA 0702 Trial)

NCT00932412 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

735

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: CLARA
DRUG: HDAc

Sponsor

Hospices Civils de Lyon